range of both medicinal4 and herbicidal agents (Figure 1).5 While
the asymmetric syntheses of 1 and 2 have been reported,6 each
pose formidable challenges due to starting material availability,
length of synthesis, and low-yielding transformations which are
most likely due to the sterically hindered nature of 1. Classical
resolution strategies have also been reported;7 however, com-
plete procedures are scarce since racemic 1 is not readily
available and many procedures are only found in published
patents which are often difficult to interpret and often lack
complete accounts of experimental details. In this paper, we
document a full description of an experimentally simplified
protocol for the three-step preparation of (S)-N-ethoxycarbonyl-
R-methylvaline 3 which is amenable to large scale and offers
significant advantages over currently available methodologies.
A Concise Synthesis of
(S)-N-Ethoxycarbonyl-r-methylvaline
Jeffrey T. Kuethe,* Donald R. Gauthier, Jr.,
Gregory L. Beutner, and Nobuyoshi Yasuda
Department of Process Research, Merck & Co., Inc., P.O. Box
2000, Rahway, New Jersey 07065
ReceiVed June 18, 2007
A practical and efficient protocol for the three-step synthesis
of (S)-N-ethoxycarbonyl-R-methylvaline 3 is described which
utilizes readily available commercial starting materials. The
key transformations involve resolution-crystallization of
tartrate salt 6 followed by a one-pot procedure for the
preparation of 3 which is isolated as the dicyclohexylamine
salt in 45% overall yield and in 91-95% ee.
FIGURE 1. Methylvaline and derivatives.
The synthesis of 3 began with the Strecker reaction of
3-methyl-2-butanone 4 (Scheme 1). Reaction of 4 with 0.95
equiv of NaCN in the presence of 0.5 equiv of NH4Cl and 0.5
equiv of MgSO4 in 7 M NH3 in MeOH (3.0 equiv) at 30 °C
The preparation of R-methyl-R-substituted amino acids as
unnatural amino acid analogues has received considerable
interest due to restricted conformational freedom and the
tendency to induce 310-, R-helical, and â-turn-type conforma-
tions when incorporated in peptide chains,1 and these compounds
have been incorporated into marketed pharmaceuticals such as
Aldomet (L-R-methylDOPA).2 Since R-methyl-R-substituted
amino acids are unable to undergo racemization, these nonpro-
teinogenic building blocks can impart significant changes in
biological activities and have found applications in enzyme
mimetics and in de novo design of proteins.3 As R-methyl-R-
substituted amino acids are rarely found in nature, the prepara-
tion of these increasingly important building blocks in high yield
and enantiopure form, by methods that are also amenable to
large scale, underscores the importance of developing new
methodologies. In particular, R-methylvaline 1 and its amide
derivative 2 have been used extensively in the preparation of a
(4) For leading references, see: (a) Fitch, D. M.; Evans, K. A.; Chai,
D.; Duffy, K. J. Org. Lett. 2005, 7, 5521. (b) Shen, D.-M.; Shu, M.;
Willoughby, C. A.; Shah, S.; Lynch, C. L.; Hale, J. J.; Mills, S. G.;
Chapman, K. T.; Malkowitz, L.; Springer, M. S.; Gould, S. L.; DeMartino,
J. A.; Siciliano, S. J.; Lyons, K.; Pivnichny, J. V.; Kwei, G. Y.; Carella,
A.; Carver, G.; Holmes, K.; Schleif, W. A.; Danzeisen, R.; Hazuda, D.;
Kessler, J.; Lineberger, J.; Miller, M. D.; Emini, E. A. Bioorg. Med. Chem.
Lett. 2004, 14, 941. (c) Tice, C. M.; Hormann, R. E.; Thompson, C. S.;
Friz, J. L.; Cavanaugh, C. K.; Michelotti, E. L.; Garcia, J.; Nicolas, E.;
Albericio, F. Bioorg. Med. Chem. Lett. 2003, 13, 475.
(5) (a) Los, M. US Patent 4554013, 1985. (b) Orwick, P. L.; Templeton,
A. R. US Patent 4404012, 1983. (c) Los, M. US Patent 4017510, 1977. (d)
Gastrock, W. H.; Wepplo, P. J. US Patent 4683324, 1987. (e) Eur. Patent
0,123.830, 1984.
(6) (a) Seebach, D.; Aebi, J. D.; Naef, R.; Weber, T. HelV. Chim. Acta
1985, 68, 144. (b) Obrecht, D.; Spiegler, C.; Scho¨nholzer, P.; Mu¨ller, K.
HelV. Chim. Acta 1992, 75, 1666. (c) Obrecht, D.; Bohdal, U.; Broger, C.;
Bur, D.; Lehmann, C.; Ruffieuz, R.; Scho¨nholzer, P.; Spiegler, C.; Mu¨ller,
K. HelV. Chem. Acta 1995, 78, 563. (d) Cativiela, C.; D´ıaz-de-Villegas, M.
D.; Ga´lvez, J. A.; Lapen˜a, Y. Tetrahedron 1995, 51, 5921. (e) Cooper, T.
S.; Laurent, P.; Moody, C. J.; Takle, A. K. Org. Biomol. Chem. 2004, 2,
265.
(7) (a) Turk, J.; Panse, G. T.; Marshall, G. R. J. Org. Chem. 1975, 40,
953. (b) Kruizinga, W. H.; Bolster, J.; Kellogg, R. M.; Kamphuis, J.;
Boesten, W. H. J.; Meijer, E. M.; Schoemaker, H. E. J. Org. Chem. 1988,
53, 1826. (c) Boesten, W. H. J.; Peters, P. J. H. Eur. Patent 150854, 1984.
(d) Sonke, T.; Kaptein, B.; Boesten, W. H. J.; Broxterman, Q. B.;
Schoemaker, W. H. J.; Kamphuis, J.; Formaggio, F.; Toniolo, C.; Rutjes,
N. In StereoselectiVe Biocatalysis; Patel, R. M., Ed.; Dekker: New York,
2000; pp 23-58. (e) Kaptein, B.; Boesten, W. H. J.; Broxterman, Q. B.;
Peters, P. J. H.; Schoemaker, H. E.; Kamphuis, J. Tetrahedron: Asymmetry
1993, 4, 1113. (f) Kaptein, B.; Broxterman, Q. B.; Schoemaker, H. E.;
Rutjes, F. P. J. T.; Veerman, J. J. N.; Kamphuis, J.; Peggion, C.; Formaggio,
F.; Toniolo, C. Tetrahedron 2001, 57, 6567.
(1) For leading references, see: (a) Formaggio, F.; Barazza, A.; Bertocco,
A.; Toniolo, C.; Broxterman, Q. B.; Kaptein, B.; Brasola, E.; Pengo, P.;
Pasquato, L.; Scrimin, P. J. Org. Chem. 2004, 69, 3849 and references cited
therein. (b) Pengo, P.; Broxtermen, Q. B.; Kaptein, B.; Pasquato, L.; Scrimin,
P. Langmuir 2003, 19, 2521. (c) Karle, I. L.; Balaram, P. Biochemistry
1990, 29, 6747. (d) Mutter, M. Angew Chem. 1985, 97, 639.
(2) Reinhold, D. F.; Firestone, R. A.; Gaines, W. A.; Chemerda, J. M.;
Sletzinger, M. J. Org. Chem. 1968, 33, 1209 and references cited therein.
(3) For recent reviews, see: (a) Andrews, M. J. I.; Tabor, A. B.
Tetrahedron 1999, 55, 11711. (b) Venkatraman, J.; Shankaramma, S. C.;
Balaram, P. Chem. ReV. 2001, 101, 3131. (c) Licini, G.; Prins, L.; Scrimin,
P. Eur. J. Org. Chem. 2005, 969. (d) Ohfune, Y.; Shinada, T. Eur. J. Org.
Chem. 2005, 5127. (e) Cativiela, C.; D´ıaz-de-Villega, M. D. Tetrahedron:
Asymmetry 2007, 18, 569. (f) Vogt, H.; Bra¨se, S. Org. Biomol. Chem. 2007,
5, 406.
10.1021/jo7012862 CCC: $37.00 © 2007 American Chemical Society
Published on Web 08/22/2007
J. Org. Chem. 2007, 72, 7469-7472
7469